David Baram: Founder and CEO of EmendoBio

Portrait of David Baram

David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

Shionogi

An Opportunity Pipeline

Gemini Therapeutics employee in lab.
Gemini Therapeutics

We See Disease Differently

1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending